🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsRetatrutide & Triple AgonistsTRIUMPH program trial design overview — all Phase 3 arms Page 9

TRIUMPH program trial design overview — all Phase 3 arms

TrialTracker_MD Mon, Feb 26, 2024 at 4:00 PM 324 replies 45,778 viewsPage 9 of 20
Dr.ObesityMed
VIP Member
3,456
19,234
Nov 2023
Denver, CO
Online
May 20, 2024 at 11:41 PM#41
VendorMark said:
For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.

This is where I part company with the consensus forming above. Not convinced. The evidence being cited is consistent with the conclusion and also consistent with two other conclusions nobody has ruled out.

39 14EndoResFellow, PharmacoVig_BOS, SurmountFan_IN and 36 others
Reply Quote Save Share Report
JennaRN
Senior Member
1,987
8,923
Mar 2024
Colorado
Online
May 24, 2024 at 1:29 PM#42
VendorMark said:
For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.

Correct as far as it goes. The part it does not cover is what to do when the honest answer is "not enough data", which is more often than anyone likes.

38 13PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 35 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
May 28, 2024 at 3:15 AM#43

Moderator note: reminder that nothing in this thread is medical advice, and that clinical claims need a source. Tagging this one for the weekly digest.

37 12RegAffairsDC, BiostatsBrad, PeptideSynthNJ and 34 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
EndoResFellow
Member
456
2,345
Sep 2024
Baltimore, MD
May 31, 2024 at 4:59 PM#44

Clinical perspective, offered as context rather than as advice. Whatever the answer turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, and invite the correction. That is slower than asserting, and it is the only version that survives being wrong.

Correct me if the detail matters more than I have assumed.

Last edited: May 31, 2024 at 6:59 PM
36 11NurseKim_ATL, paul_denver, TinaHashiRN and 33 others
Reply Quote Save Share Report
JenPlateau
Member
234
890
Nov 2024
Missouri
Jun 4, 2024 at 6:41 AM#45
EndoResFellow said:
Whatever the answer turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, and invite the…

Mine went the same way, slower. I had assumed I was the exception until I read this.

Last edited: Jun 4, 2024 at 12:41 PM
35 10sarah_nash92, FitDadDave, RunnerRach and 32 others
Reply Quote Save Share Report

Similar Threads

TRIUMPH-3 topline results — 24.2% body weight loss at 48 weeks10 replies
Retatrutide mechanism: GLP-1/GIP/glucagon triple agonism explained5 replies
Retatrutide Phase 2 dose-response analysis — optimal dose range10 replies
Glucagon receptor agonism and hepatic lipid oxidation — MASH implications13 replies
Retatrutide vs tirzepatide — dual vs triple agonist comparison22 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register